ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease –– ARV-102 demonstrated ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...

Arvinas has announced positive biomarker, pharmacokinetic and pharmacodynamic data from two Phase I studies assessing ARV-102 ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET ...

Fighting Alzheimer’s disease is a race against time. By the time most patients are diagnosed and treated, their cognitive symptoms have already advanced significantly. New research, though, pinpoints ...

Scientists at the Institute for Basic Science (IBS) have uncovered a non-invasive method to boost the brain's natural waste drainage system—a discovery that could open new avenues for tackling ...

VIRTUAL MEETING (CST), November 22, 2020 -- Swelling is one of the most dangerous and immediate consequences of a brain injury or stroke. Doctors have long known about the dangers of swelling, which ...

- Preclinical data support rationale for targeting GM-CSF in GCA – - Mavrilimumab showsbiological effect on genes relevant to GCA pathophysiology in ex vivo cultures of GCA arteries – HAMILTON, ...